Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04005859
Other study ID # 01-18-16
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date February 22, 2018
Est. completion date July 20, 2021

Study information

Verified date October 2021
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare the analgesic impact of intravenous perioperative lidocaine infusion with preoperative liposomal bupivacaine TAP block in colorectal surgery. This is to be integrated into the standard ERAS protocol currently utilized at Carolinas Medical Center. Primary endpoints will be postoperative pain as measured by verbal rate scale (VRS), postoperative morphine equivalents utilized per day, and over 30 days. Secondary endpoints will include date of ambulation, return of bowel function (first flatus), tolerance of goal diet, incidence of post-operative nausea and vomiting during hospital stay, length of stay (hospital and PACU), post-operative morbidity (Clavien-Dindo, related to both anesthesia and surgery), cost of hospitalization (operative, PACU, postoperative stay, and total) and quality of life on follow up.


Recruitment information / eligibility

Status Completed
Enrollment 61
Est. completion date July 20, 2021
Est. primary completion date May 9, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Age 18-75 years - Elective laparoscopic colorectal surgery - ASA I-III Exclusion Criteria: - Contraindication to Na Channel Blocker - Chronic Opioid use - Liver dysfunction - Renal insufficiency - Epilepsy - Psychomotor retardation - BMI >40 - Sleep Apnea - Cardiac Rhythm Disorders - Planned open or concomitant procedure

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Exparel
2. Liposomal bupivacaine TAP block (experimental arm) Block will be administered after induction of anesthesia and before incision by a specifically trained attending surgeon or surgical fellow with the colorectal service. A single vial of liposomal bupivacaine (20 mL 1.3%, 13.3mg/mL, 266 mg) will be diluted in 50cc bupivacaine to a volume of 60cc prior to administration. This will be divided into 2 doses for bilateral TAP blocks. The LB will be administered under ultrasound guidance in the transversus abdominis plain per manufacturer recommendations. Adhesive tapes will be applied at the level of the TAP block puncture sites.
IV Lidocaine
1. Intravenous Lidocaine infusion (control arm, current standard of care) 100 mg/5mL intravenous bolus of lidocaine 2% PF 5mL will be initiated by anesthesia service prior to general anesthesia induction. 1.5 mg/kg/hr to begin prior to incision and continue until discontinued 1 hr postoperatively in PACU. Patients will be monitored in PACU for at least 30 minutes after discontinuation of lidocaine drip. Adhesive tapes will be applied at the presumed level of TAP block puncture sites.

Locations

Country Name City State
United States Atrium Health - Carolinas Medical Center Charlotte North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Wake Forest University Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Verbal Pain Scale (VRS) - 4 Week Post-op Postoperative pain was measured by verbal rate scale (VRS) Scale of 0-10 at instance of 4-week post-op visit (or phone call). 0 represents no pain while 10 represents worst possible pain. Single VRS assessed at 4-week post-op visit (or phone call)
See also
  Status Clinical Trial Phase
Recruiting NCT05005117 - Laparoscopic Approach for Emergency Colon Resection N/A
Completed NCT04516785 - Reducing Colonoscopies in Patients Without Significant Bowel Disease
Completed NCT05994326 - Perioperative Care and Short-term Outcomes of Colorectal Surgery in Addis Abeba
Recruiting NCT05432934 - Transversus Abdominis Plane Blocks With and Without Dexamethasone Phase 1/Phase 2
Recruiting NCT03935451 - Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease Early Phase 1
Recruiting NCT05726136 - Fluid Challenge and Plasma Volume, During Surgery Phase 4
Completed NCT04849702 - Comparison of the Clavien-Dindo and Comprehensive Complication Index
Not yet recruiting NCT06008834 - First-day Discharge Enhanced Recovery After Surgery Protocol for Minimal Invasive Colorectal Surgery N/A
Completed NCT04550156 - Evaluation of the Introduction of a Colorectal Bundle in Left Sided Colorectal Resections N/A
Completed NCT04748744 - Value of Butyrylcholinesterase as a Marker of Surgical Site Infection Following Surgery for Colorectal Diseases
Completed NCT02364895 - ColonCancerCheck Mailed Invitations: An Evaluation N/A
Completed NCT05531331 - The Effect of Education on Self-Efficacy and Adaptation to Stoma of Individuals With Stoma N/A
Recruiting NCT04236128 - Home to Stay Mobile App for Colorectal Surgery N/A
Not yet recruiting NCT06356558 - Adapting Enhanced Recovery Programs for Low Health Literacy Patients N/A
Completed NCT02449720 - Intraperitoneal Local Anaesthetic in Bowel Surgery Phase 4
Withdrawn NCT01592630 - Effectiveness of Transverse Abdominus Plane Catheter Blocks to Patient-controlled Analgesia in Laparoscopic Colon Resections Phase 3
Completed NCT00868400 - Clinical Value of Preoperative Oral Carbohydrate Loading in Colorectal Surgery N/A
Completed NCT03985111 - Does a Central Venous Line Reduce Perioperative Fluid Administration?
Not yet recruiting NCT04704817 - Prospective Database for Colonic or Rectal Resection Surgery Patients
Completed NCT02940665 - A Comparison of Protein Intake Between ERAS and Conventional Care After Elective Colorectal Surgery N/A